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Identity 
Other names: hSNF5; SNF5L1; INI1 (integrase 
interactor 1); BAF47 (BRG1-associated factor) 
HGNC (Hugo): SMARCB1 
Location: 22q11.2 
Local order: Distal to BCR. 
DNA/RNA 
Description 
Spans over 50 kb; 9 exons. 
Transcription 
Alternative splicing including/excluding exon 2. 
Protein 
Description 
385 amino acids; 47 kDa; a DNA binding domain and 2 
repeat motifs. 
Localisation 
Nucleus; associated with the chromatin and with the 
nuclear matrix. 
Function 
Binds and activates human immunodeficiency virus 
integrase; member of the SWI/SNF complex, thought 
to facilitate the transcriptional activation of inducible 
genes through the remodelling of the chromatin; could 
be involved in the chromatin organization associated 
with the nuclear matrix attachment; could also have a 
role in the cell cycle control, through binding to P105-
Rb. 
Homology 
with SNF5 (yeast transcription factor) 
Mutations 
Germinal 
Found in the rhabdoid tumor predisposition syndrome. 
Somatic 
Mutation and allele loss events in sporadic rhabdoid 
tumors are consistent with the two-hit model of 
Knutson; deletion of the entire gene on one allele 
(sometimes due to translocations involving 22q11), and 
mutation (frameshift mutations, widely dispersed 
through the entire gene and leading to stop codons) on 




Tumor of uncertain origin, occuring in early childhood. 
Prognosis 
Highly aggressive; 80% mortality rate. 
Cytogenetics 
Normal karyotype or t(Var; 22)(-;q11.2). 
Hybrid/Mutated gene 
No hybrid gene but inactivation of both alleles. 
Rhabdoid tumor predisposition 
syndrome 
Hybrid/Mutated gene 
Germline mutation on one allele, predisposing to a  
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rhabdoid tumor (and perhaps to tumors of the central 
nervous system) when the other allele is also 
inactivated. 
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